tradingkey.logo
tradingkey.logo
Search

Kura Oncology Inc

KURA
Add to Watchlist
9.010USD
-0.300-3.22%
Close 07-31 16:00ETQuotes delayed by 15 min
799.86MMarket Cap
LossP/E TTM

KURA Financials

See Kura Oncology Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Kura Oncology Inc Earnings Date

Latest Release
May 12, 2026
EPS / Forecast
-0.83/-0.63
Revenue / Forecast
18.27M/18.51M
Period
FY2025 Earnings
Revenue(YoY)
67.48M
25.24%
EPS(YoY)
-3.18
-57.40%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-25.97%-0.83
-317.12%-0.92
-35.15%-0.85
-28.65%-0.75
-11.30%-0.66
60.12%-0.22
-25.20%-0.63
-10.17%-0.59
-18.51%-0.59
-13.20%-0.55
---0.50
---0.53
---0.50
---0.49
---1.54
----
----
----
----
----
Revenue
29.47%18.27M
-67.83%17.34M
--20.75M
--15.29M
--14.11M
--53.88M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net Profit
-27.69%-73.33M
-321.50%-81.00M
-36.23%-74.12M
-30.07%-66.12M
-15.96%-57.43M
55.09%-19.22M
-40.94%-54.40M
-36.75%-50.84M
-45.37%-49.52M
-29.21%-42.79M
-8.73%-38.60M
-6.92%-37.17M
-4.98%-34.07M
-1.13%-33.11M
-6.41%-35.50M
-3.29%-34.77M
-5.73%-32.45M
-25.17%-32.74M
-40.38%-33.37M
-64.31%-33.66M
Net Margin
1.37%-401.49%
-1210.08%-467.23%
---357.19%
---432.51%
---407.07%
---35.66%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Gross Margin
-1.43%98.57%
-0.33%99.67%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Debt to assets ratio
16.10%1.49%
4.98%1.32%
-24.70%1.49%
-22.93%1.41%
-23.98%1.29%
-39.73%1.25%
0.89%1.98%
-2.10%1.83%
-21.63%1.69%
3.57%2.08%
--1.96%
--1.87%
--2.16%
--2.01%
----
----
----
----
----
----
Revenue
29.47%18.27M
-67.83%17.34M
--20.75M
--15.29M
--14.11M
--53.88M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating profit
-21.82%-78.81M
-284.18%-86.27M
-33.59%-80.00M
-28.83%-72.67M
-18.82%-64.70M
51.98%-22.45M
-40.99%-59.88M
-41.00%-56.40M
-48.91%-54.45M
-33.01%-46.76M
-16.07%-42.47M
-13.22%-40.00M
-11.54%-36.57M
-6.41%-35.16M
-8.66%-36.59M
-5.01%-35.33M
-6.10%-32.78M
-25.47%-33.04M
-39.20%-33.68M
-58.91%-33.65M
Net Profit
-27.69%-73.33M
-321.50%-81.00M
-36.23%-74.12M
-30.07%-66.12M
-15.96%-57.43M
55.09%-19.22M
-40.94%-54.40M
-36.75%-50.84M
-45.37%-49.52M
-29.21%-42.79M
-8.73%-38.60M
-6.92%-37.17M
-4.98%-34.07M
-1.13%-33.11M
-6.41%-35.50M
-3.29%-34.77M
-5.73%-32.45M
-25.17%-32.74M
-40.38%-33.37M
-64.31%-33.66M
Current assets
-13.87%623.78M
-4.86%708.66M
34.00%620.66M
32.08%660.08M
34.65%724.20M
72.22%744.83M
0.71%463.19M
2.91%499.77M
29.15%537.84M
-3.12%432.48M
5.39%459.92M
5.62%485.65M
-14.49%416.45M
-14.53%446.43M
-20.50%436.39M
-19.85%459.79M
-20.25%487.03M
-18.05%522.29M
66.89%548.90M
67.64%573.63M
Total current liabilities
13.07%101.50M
48.61%116.97M
200.47%121.30M
220.39%107.17M
178.21%89.77M
123.21%78.71M
46.67%40.37M
39.97%33.45M
67.76%32.27M
46.58%35.26M
11.23%27.52M
33.72%23.90M
8.51%19.23M
7.13%24.06M
12.86%24.75M
-16.05%17.87M
-29.49%17.73M
-13.71%22.45M
1.02%21.93M
14.76%21.29M
Total assets
-12.26%652.55M
-2.87%738.36M
35.62%649.38M
32.48%682.42M
34.28%743.76M
69.32%760.16M
1.07%478.84M
4.12%515.12M
30.03%553.91M
-1.62%448.94M
5.76%473.77M
4.95%494.74M
-14.56%425.98M
-14.56%456.31M
-20.16%447.99M
-19.40%471.43M
-19.62%498.58M
-17.48%534.05M
65.25%561.14M
65.69%584.89M
Total liabilities
43.58%544.67M
62.83%564.23M
638.82%406.84M
668.54%376.94M
676.99%379.36M
570.74%346.52M
25.62%55.07M
39.90%49.05M
58.56%48.82M
43.39%51.66M
54.52%43.83M
59.84%35.06M
37.86%30.79M
31.29%36.03M
3.59%28.37M
-16.73%21.93M
-34.84%22.34M
-24.42%27.44M
-17.20%27.39M
-13.99%26.34M
Total equity
-70.39%107.88M
-57.90%174.13M
-42.77%242.54M
-34.45%305.49M
-27.85%364.41M
4.12%413.64M
-1.43%423.77M
1.39%466.07M
27.81%505.08M
-5.47%397.27M
2.46%429.94M
2.27%459.68M
-17.02%395.18M
-17.04%420.28M
-21.38%419.62M
-19.53%449.49M
-18.73%476.25M
-17.07%506.61M
74.15%533.76M
73.26%558.55M
Net operating income
-19.36%-85.85M
-56.43%117.27M
-85.61%-80.63M
32.34%-28.78M
-47.26%-71.93M
884.46%269.13M
-49.65%-43.44M
-66.02%-42.53M
-36.16%-48.84M
-29.32%-34.31M
-38.16%-29.03M
15.57%-25.62M
-11.47%-35.87M
-13.54%-26.53M
14.57%-21.01M
-8.08%-30.34M
-12.85%-32.18M
-27.63%-23.37M
-44.96%-24.59M
-90.54%-28.07M
Net investment
76.11%-24.23M
31.97%-64.60M
106.36%93.97M
36.54%58.94M
-6.37%-101.41M
-325.04%-94.95M
432.01%45.53M
193.18%43.17M
-956.65%-95.34M
189.17%42.20M
-88.08%8.56M
-239.97%-46.33M
144.58%11.13M
-163.89%-47.32M
218.52%71.81M
188.92%33.10M
86.60%-24.96M
223.05%74.06M
149.53%22.55M
-71.63%-37.22M
Net financing
-51.75%69.00K
40.82%1.14M
-100.00%0.00
-83.06%515.00K
-99.90%143.00K
16.64%806.00K
2521.43%2.20M
-96.77%3.04M
--148.37M
-98.01%691.00K
-90.45%84.00K
3422.22%94.01M
-100.00%0.00
4271.91%34.71M
-61.03%880.00K
140.65%2.67M
283.54%303.00K
-99.76%794.00K
-51.78%2.26M
-104.78%-6.57M

FAQs

What is the total revenue of Kura Oncology Inc?

According to Kura Oncology Inc's FY2025 earnings report, its total revenue reached 67.48M, with a year-on-year change of 53.88M.

What are the current assets of Kura Oncology Inc?

According to Kura Oncology Inc's FY2025 earnings report, its current assets were 708.66M, with a year-on-year change of -4.86.

What are the total assets of Kura Oncology Inc?

According to Kura Oncology Inc's FY2025 earnings report, its total assets of Kura Oncology Inc were 738.36M, with a year-on-year change of -2.87.

What are the total liabilities of Kura Oncology Inc?

According to Kura Oncology Inc's FY2025 earnings report, its total liabilities of Kura Oncology Inc were 564.23M, with a year-on-year change of 62.83.

What is the total equity of Kura Oncology Inc?

According to Kura Oncology Inc's FY2025 earnings report, its total equity of Kura Oncology Inc was 174.13M, with a year-on-year change of -57.90.

What is the net operating income of Kura Oncology Inc?

According to Kura Oncology Inc's FY2025 earnings report, its net operating income of Kura Oncology Inc was -303.63M, with a year-on-year change of -57.16.

What is the net investment of Kura Oncology Inc?

According to Kura Oncology Inc's FY2025 earnings report, its net investment of Kura Oncology Inc was -13.10M, with a year-on-year change of 87.11.

What is the net financing of Kura Oncology Inc?

According to Kura Oncology Inc's FY2025 earnings report, its net financing of Kura Oncology Inc was 1.79M, with a year-on-year change of -98.84.

What is the Earnings Per Share (EPS) of Kura Oncology Inc?

According to Kura Oncology Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.18, with a year-on-year change of -57.40.

What is the net income of Kura Oncology Inc?

According to Kura Oncology Inc's FY2025 earnings report, its net income was -278.67M, with a year-on-year change of -60.17.

What is the net margin of Kura Oncology Inc?

According to Kura Oncology Inc's FY2025 earnings report, its net profit margin was -412.95, with a year-on-year change of -27.89.

What is the gross margin of Kura Oncology Inc?

According to Kura Oncology Inc's FY2025 earnings report, its gross margin was 99.92, with a year-on-year change of -0.08.

What is the debt-to-asset ratio of Kura Oncology Inc?

According to Kura Oncology Inc's FY2025 earnings report, its debt-to-asset ratio was 1.32, with a year-on-year change of 4.98.

What is the Return on Equity (ROE) of Kura Oncology Inc?

According to Kura Oncology Inc's FY2025 earnings report, its Return on Equity (ROE) was -94.82, with a year-on-year change of -120.97.

What is the Return on Assets (ROA) of Kura Oncology Inc?

According to Kura Oncology Inc's FY2025 earnings report, its Return on Assets (ROA) was -37.19, with a year-on-year change of -29.23.

What is the operating profit of Kura Oncology Inc?

According to Kura Oncology Inc's FY2025 earnings report, its operating profit was -303.63M, with a year-on-year change of -57.16.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.